Clinical Trial Update: Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System [NA]

View source ↗

Summary

Completed early feasibility study of the Edwards FORMA Tricuspid Transcatheter Repair System for tricuspid valve regurgitation; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Valve Regurgitation

Drugs mentioned

• FORMA Tricuspid Transcatheter Repair System (FORMA Tricuspid Transcatheter Repair System)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Tricuspid Valve Regurgitation | NA | Status: COMPLETED | Results posted: 2022-01-06